Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
0.9620
-0.0580 (-5.69%)
At close: Dec 29, 2025, 4:00 PM EST
0.9220
-0.0400 (-4.16%)
After-hours: Dec 29, 2025, 7:56 PM EST
Mustang Bio Market Cap
Mustang Bio has a market cap or net worth of $7.02 million as of December 29, 2025. Its market cap has decreased by -21.11% in one year.
Market Cap
7.02M
Enterprise Value
-11.80M
1-Year Change
-21.11%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since August 22, 2017, Mustang Bio's market cap has decreased from $257.00M to $7.02M, a decrease of -97.27%. That is a compound annual growth rate of -35.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 7.40M | -12.94% |
| Dec 31, 2024 | 8.50M | -31.45% |
| Dec 29, 2023 | 12.40M | -70.75% |
| Dec 30, 2022 | 42.40M | -72.66% |
| Dec 31, 2021 | 155.10M | -37.18% |
| Dec 31, 2020 | 246.90M | 49.18% |
| Dec 31, 2019 | 165.50M | 106.36% |
| Dec 31, 2018 | 80.20M | -74.50% |
| Dec 29, 2017 | 314.50M | 22.37% |
| Aug 22, 2017 | 257.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.04B |
| Johnson & Johnson | 501.64B |
| AbbVie | 407.91B |
| UnitedHealth Group | 298.37B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.15B |
| Novo Nordisk | 232.28B |